CrystalGenomics made a contract to sell the new drug, ‘Acelex’, with Daewoong Pharmaceutical

The new drug bio venture, CrystalGenomics, officially announced on 9 February that the company made a contract with Daewoong Pharmaceutical to sell ‘Acelex (nonsteroidal anti-inflammatory drugs)’ that acquired the new drug approval on the last 5th.

CrystalGenomics and Daewoong Pharmaceutical are planning to enter the domestic market combining quality of the global new drug, Acelex, and the bes...